Der Pharmariese AbbVie fordert vor Gericht strengere Regeln ...
AbbVie revises 2026 EPS guidance after a $744M R&D charge. ...
Brompton fund combines dividend-growing giants like Microsoft ...
Pfizer wins a major EU court case for €1.9B while its ...
Un tribunal belga ordena a Polonia y RumanĂa pagar 1.900M€ ...
AbbVie revises 2026 earnings guidance down citing $744M ...
AbbVie revises 2026 EPS guidance due to a $744M charge but ...
AbbVie präsentiert vielversprechende Studiendaten in der ...
AbbVie präsentiert vielversprechende klinische Daten und ...
Auszeichnungen fĂĽr Betriebliches Gesundheitsmanagement ...
AbbVie beats Q4 2025 EPS estimates provides 2026 guidance ...
AbbVie stellt klinische Daten fĂĽr ein beschleunigt wirkendes ...
Piramal Pharma Solutions feiert das 20-jährige Jubiläum ...
Parkinson: Gerätegestützte Therapieoptionen kommen oft ...
AbbVie raises 2026 EPS guidance after strong trial data ...
Piramal Pharma Solutions Commemorates 20th Anniversary at ...
AbbVie launches a multi-year MLB charity campaign while ...
Der Pharmakonzern AbbVie startet eine mehrjährige Partnerschaft ...
Der Vanguard Health Care ETF ändert seinen Status auf nicht-diversifiziert ...
Tag der pharmazeutischen Industrie 2026: Pharmastandort ...
WisdomTree U.S. High Dividend Fund (DHS) rebalances portfolio ...
Der WisdomTree U.S. High Dividend Fund bereitet seine nächste ...
A pesar de récords de ventas con Mounjaro y Zepbound la ...
Eli Lilly shares fall despite blockbuster Q4 results. Investors ...
AbbVie declares $1.73 dividend reaffirms Aristocrat status. ...
El futuro de BioNTech depende de sus ensayos clĂnicos en ...
AbbVie pivots to holistic aesthetics care as patient preferences ...
AbbVie fokussiert sich auf ganzheitliche Behandlungen in ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions présente des capacités de comprimé ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Werk von Piramal Pharma Solutions im schottischen Grangemouth ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Werk von Piramal Pharma Solutions im schottischen Grangemouth ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Der Einsatz von Medikamenten zur Gewichtsreduktion erhöht ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Piramal Pharma Solutions présente des capacités de comprimé ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Werk von Piramal Pharma Solutions im schottischen Grangemouth ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Werk von Piramal Pharma Solutions im schottischen Grangemouth ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...
Piramal Pharma Solutions présente des capacités de comprimé ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Piramal Pharma Solutions' Grangemouth UK Facility Successfully ...
Lo stabilimento di Grangemouth nel Regno Unito di Piramal ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Ein US-Gericht lässt eine Klage wegen Medikamentenpreisen ...
Piramal Pharma Solutions introduce la tecnologia tablet-in-capsule ...